Research Article
BibTex RIS Cite

Activated protein c resistance in myocardial infarction

Year 1997, Volume: 10 Issue: 2, 84 - 86, 01.03.1997

Abstract

Objective: The aim of this study is to investigate the role of activated protein C resistance (APCR) as a contributing factor in the pathogenesis of myocardial infarction.

Methods: Forty patients with acute myocardial infarction (AMI) who have been followed by the Cardiology Department of Gülhane Military Medical Academy Haydarpaşa Training Hospital and 30 healthy individuals were included in this study. Patient group consisted of 27 males and 13 females, (mean age 47.9 (23-81) control group composed of 16 males and 14 females, (mean age 46.1 (24-63) Whole blood count and routine biochemical work up were performed and activated protein C resistance (APCR) ratio, and activated partial thromboplastin time were evaluated in both groups.

Results: Two patients and three controls had APCR. Mean APCR ratio was 2.56 ± 0.56 in the control and 2.74 ± 0.67 in the patient group and there was no statistically significant difference between the two groups (p>0.05).

Conclusion: Although APCR is a major risk factor for venous thrombosis, its role

References

  • Davides MJ, Thomas A. Thrombosis and acute coronary artery lesions in sudden ischemic death, H EngJMed 1984,310:1137-1140.
Year 1997, Volume: 10 Issue: 2, 84 - 86, 01.03.1997

Abstract

References

  • Davides MJ, Thomas A. Thrombosis and acute coronary artery lesions in sudden ischemic death, H EngJMed 1984,310:1137-1140.
There are 1 citations in total.

Details

Subjects Clinical Sciences
Journal Section Derleme
Authors

B. S. Cebeci This is me

B. Y. Cingözbay This is me

A. Öztürk This is me

M. Coşkun This is me

N. Üskent This is me

Publication Date March 1, 1997
Published in Issue Year 1997 Volume: 10 Issue: 2

Cite

APA Cebeci, B. S., Cingözbay, B. Y., Öztürk, A., Coşkun, M., et al. (1997). Activated protein c resistance in myocardial infarction. Marmara Medical Journal, 10(2), 84-86.
AMA Cebeci BS, Cingözbay BY, Öztürk A, Coşkun M, Üskent N. Activated protein c resistance in myocardial infarction. Marmara Med J. March 1997;10(2):84-86.
Chicago Cebeci, B. S., B. Y. Cingözbay, A. Öztürk, M. Coşkun, and N. Üskent. “Activated Protein C Resistance in Myocardial Infarction”. Marmara Medical Journal 10, no. 2 (March 1997): 84-86.
EndNote Cebeci BS, Cingözbay BY, Öztürk A, Coşkun M, Üskent N (March 1, 1997) Activated protein c resistance in myocardial infarction. Marmara Medical Journal 10 2 84–86.
IEEE B. S. Cebeci, B. Y. Cingözbay, A. Öztürk, M. Coşkun, and N. Üskent, “Activated protein c resistance in myocardial infarction”, Marmara Med J, vol. 10, no. 2, pp. 84–86, 1997.
ISNAD Cebeci, B. S. et al. “Activated Protein C Resistance in Myocardial Infarction”. Marmara Medical Journal 10/2 (March 1997), 84-86.
JAMA Cebeci BS, Cingözbay BY, Öztürk A, Coşkun M, Üskent N. Activated protein c resistance in myocardial infarction. Marmara Med J. 1997;10:84–86.
MLA Cebeci, B. S. et al. “Activated Protein C Resistance in Myocardial Infarction”. Marmara Medical Journal, vol. 10, no. 2, 1997, pp. 84-86.
Vancouver Cebeci BS, Cingözbay BY, Öztürk A, Coşkun M, Üskent N. Activated protein c resistance in myocardial infarction. Marmara Med J. 1997;10(2):84-6.